# Organon & Co. (OGN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/ogn for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: NYSE · Trading currency: USD

Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $13.75 USD |
| Market Cap | $3.61B |
| P/E (TTM) | 4.30 |
| EPS (TTM) | $3.20 |
| 52-Week Range | $5.69 – $13.83 |
| Dividend Yield (TTM) | 0.58% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 0.58% |
| Annual Dividend (TTM) | $0.08 /share |
| Annual Dividend (Forward) | $0.08 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 0.0% / -58.5% / -41.0% / — |
| Payout Ratio (EPS, TTM) | 10.4% |
| Payout Ratio (FCF, TTM) | 4.2% |
| Payout Ratio (EPS, forward dividend) | 10.4% |
| Payout Ratio (FCF, forward dividend) | 4.2% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-08-14 | $0.0200 | 2026-09-10 |
| 2026-05-11 | $0.0200 | 2026-06-11 |
| 2026-02-23 | $0.0200 | 2026-03-12 |
| 2025-11-20 | $0.0200 | 2025-12-11 |
| 2025-08-15 | $0.0200 | 2025-09-11 |
| 2025-05-12 | $0.0200 | 2025-06-12 |
| 2025-02-24 | $0.2800 | 2025-03-13 |
| 2024-11-12 | $0.2800 | 2024-12-12 |
| 2024-08-16 | $0.2800 | 2024-09-12 |
| 2024-05-10 | $0.2800 | 2024-06-13 |
| 2024-02-23 | $0.2800 | 2024-03-14 |
| 2023-11-10 | $0.2800 | 2023-12-14 |

Full history: https://www.dividenddata.com/stocks/ogn/dividend

## Frequently Asked Questions

### What does Organon & Co. do?

Organon & Co. (OGN) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is OGN's market cap?

Organon & Co. (OGN) has a market capitalization of approximately $3.61 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does OGN pay a dividend?

Yes, Organon & Co. (OGN) pays a dividend quarterly, with a trailing-twelve-month yield of 0.58%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does OGN pay dividends?

Organon & Co. pays dividends quarterly. The forward annual rate is $0.08 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is OGN's payout ratio?

Organon & Co.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/ogn
- Dividend history & safety: https://www.dividenddata.com/stocks/ogn/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/ogn/earnings
- Financial statements: https://www.dividenddata.com/stocks/ogn/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/ogn/valuation
- Peer comparison: https://www.dividenddata.com/stocks/ogn/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.